Review




Structured Review

Burning Rock Biotech Ltd capture-based targeted sequencing panel
Capture Based Targeted Sequencing Panel, supplied by Burning Rock Biotech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/capture+based+targeted+sequencing+panel/pmc09811622__Supplementary_Data-35-5-9
Average 90 stars, based on 1 article reviews
capture-based targeted sequencing panel - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Targeted Sequencing:

Article Title: Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples.
Article Snippet: DNA fragmentation was detected on an Agilent 2100 Bioanalyzer. .. The 60 matched tumor tissue samples were processed using a commercially available, capture- based targeted sequencing panel (Burning Rock Biotech Ltd., Guangzhou, China), targeting 295 genes, including 12 tumor- relevant signaling pathway kinases, 65 drug targets, and 107 well- established oncogene or tumor suppressor genes (see Table S2). ..

Article Title: BTK inhibitor combined with anti-PD-1 monoclonal antibody for the treatment of CD20-negative primary central nervous system lymphoma: A case report
Article Snippet: .. DNA was profiled using a capture‐based targeted sequencing panel (Burning Rock Biotech, Ltd.), targeting 112 genes and spanning 314 K of Human genomic regions. ..

Article Title: Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next‐Generation Sequencing With Insufficient Tumor Samples
Article Snippet: DNA fragmentation was detected on an Agilent 2100 Bioanalyzer. .. The 60 matched tumor tissue samples were processed using a commercially available, capture‐based targeted sequencing panel (Burning Rock Biotech Ltd., Guangzhou, China), targeting 295 genes, including 12 tumor‐relevant signaling pathway kinases, 65 drug targets, and 107 well‐established oncogene or tumor suppressor genes (see Table ). ..

other:

Article Title: Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib
Article Snippet: DNA was profiled using a commercially available capture-based sequencing panel (Burning Rock Biotech Ltd, Guangzhou, P.R.

Isolation:

Article Title: Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer.
Article Snippet: a Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China b Graduate School, University of South China, Hengyang, Hunan, 421001, China c Department of Pharmacy, Hunan Cancer Hospital, Changsha, 410011, China d Center of New Drug Clinical Trials, Hunan Cancer Hospital, Changsha, 410011, China e Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China f Burning Rock Biotech, Guangzhou, 510300, China g Department of Medical Oncology, Qinghai Provincial People’s Hospital, Xining, China h Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA

Next-Generation Sequencing:

Article Title: Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer.
Article Snippet: a Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China b Graduate School, University of South China, Hengyang, Hunan, 421001, China c Department of Pharmacy, Hunan Cancer Hospital, Changsha, 410011, China d Center of New Drug Clinical Trials, Hunan Cancer Hospital, Changsha, 410011, China e Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China f Burning Rock Biotech, Guangzhou, 510300, China g Department of Medical Oncology, Qinghai Provincial People’s Hospital, Xining, China h Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA

Sequencing:

Article Title: Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer.
Article Snippet: a Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China b Graduate School, University of South China, Hengyang, Hunan, 421001, China c Department of Pharmacy, Hunan Cancer Hospital, Changsha, 410011, China d Center of New Drug Clinical Trials, Hunan Cancer Hospital, Changsha, 410011, China e Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China f Burning Rock Biotech, Guangzhou, 510300, China g Department of Medical Oncology, Qinghai Provincial People’s Hospital, Xining, China h Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA

Article Title: A computed tomography (CT)-derived radiomics approach for predicting primary co-mutations involving TP53 and epidermal growth factor receptor ( EGFR ) in patients with advanced lung adenocarcinomas (LUAD)
Article Snippet: .. Genomic profiling was performed by using a commercially available capture based targeted sequencing panel (Burning Rock Biotech Ltd., Guangzhou, China), targeting at least 13 genes and spanning 1.44 MB of human genomic regions. ..



Similar Products

97
Twist Bioscience hybridization capture sequencing
Hybridization Capture Sequencing, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/Standard+Hybridization+Solution+v1/pmc13476044-121-1-7
Average 97 stars, based on 1 article reviews
hybridization capture sequencing - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Vazyme Biotech Co sequencing
Sequencing, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/VAHTS+mRNA+Capture+Beads+2%2E0/pm42056557-86-52-49
Average 96 stars, based on 1 article reviews
sequencing - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
New England Biolabs capture sequence h1 promoter paqci digestion site
Capture Sequence H1 Promoter Paqci Digestion Site, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/PaqCI/pm41986722-470-21-30
Average 97 stars, based on 1 article reviews
capture sequence h1 promoter paqci digestion site - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

86
Celemics Inc customized targeted capture sequencing panel
Customized Targeted Capture Sequencing Panel, supplied by Celemics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/capture+customized+panel+sequencing+targeted/pmc13144655-86-0-6
Average 86 stars, based on 1 article reviews
customized targeted capture sequencing panel - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Twist Bioscience exome capture based transcriptome sequencing rna seq assay
Exome Capture Based Transcriptome Sequencing Rna Seq Assay, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/based+capture+custom+glioma+hybrid+panel/pmc13070476-122-1-22
Average 86 stars, based on 1 article reviews
exome capture based transcriptome sequencing rna seq assay - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Twist Bioscience hybrid capture metagenomic sequencing
Hybrid Capture Metagenomic Sequencing, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/capture+probes/pm41875962-4-9-12
Average 86 stars, based on 1 article reviews
hybrid capture metagenomic sequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
10X Genomics capture tag sequence
Capture Tag Sequence, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/10x+capture+sequence/pmc12885239-103-6-4
Average 86 stars, based on 1 article reviews
capture tag sequence - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Azenta capture sequencing
(A) Mutation profiles from targeted capture <t>sequencing</t> of injected muscle tissues (S18–S19) and tumors (S1–S17), including three tumors with additional Pten mutations (S9, S13, S14). (B) Top 10 most frequently mutated genes across all tumors.
Capture Sequencing, supplied by Azenta, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/capture+sequencing/bio_rxiv__64898__2025__12__01__691734-312-1-6
Average 86 stars, based on 1 article reviews
capture sequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Zymo Research target captured dna
(A) Mutation profiles from targeted capture <t>sequencing</t> of injected muscle tissues (S18–S19) and tumors (S1–S17), including three tumors with additional Pten mutations (S9, S13, S14). (B) Top 10 most frequently mutated genes across all tumors.
Target Captured Dna, supplied by Zymo Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/Targeted+Bisulfite+Sequencing/us12442041-238-1-15
Average 90 stars, based on 1 article reviews
target captured dna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
TaKaRa 3 feature barcode capture sequence
(A) Mutation profiles from targeted capture <t>sequencing</t> of injected muscle tissues (S18–S19) and tumors (S1–S17), including three tumors with additional Pten mutations (S9, S13, S14). (B) Top 10 most frequently mutated genes across all tumors.
3 Feature Barcode Capture Sequence, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/Capture+Beads/bio_rxiv__2025__10__08__681007-230-12-25
Average 94 stars, based on 1 article reviews
3 feature barcode capture sequence - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


(A) Mutation profiles from targeted capture sequencing of injected muscle tissues (S18–S19) and tumors (S1–S17), including three tumors with additional Pten mutations (S9, S13, S14). (B) Top 10 most frequently mutated genes across all tumors.

Journal: bioRxiv

Article Title: A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of soft tissue sarcoma

doi: 10.64898/2025.12.01.691734

Figure Lengend Snippet: (A) Mutation profiles from targeted capture sequencing of injected muscle tissues (S18–S19) and tumors (S1–S17), including three tumors with additional Pten mutations (S9, S13, S14). (B) Top 10 most frequently mutated genes across all tumors.

Article Snippet: The capture sequencing was done in Azenta.

Techniques: Mutagenesis, Sequencing, Injection